Orchard Capital Management, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
Orchard Capital Management, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,207,108
+36.8%
2,142,823
+54.0%
0.82%
+50.3%
Q2 2023$1,613,653
-23.2%
1,391,0800.0%0.54%
-22.8%
Q1 2023$2,100,531
-39.6%
1,391,0800.0%0.70%
-39.7%
Q4 2022$3,477,700
-40.8%
1,391,0800.0%1.17%
-46.9%
Q3 2022$5,870,000
+105.7%
1,391,080
+35.6%
2.20%
+146.4%
Q2 2022$2,853,000
-48.4%
1,026,024
+6.1%
0.89%
-43.4%
Q1 2022$5,531,000
+65.5%
966,924
+164.2%
1.57%
+60.5%
Q4 2021$3,342,000
-12.9%
366,004
+2.0%
0.98%
-15.2%
Q3 2021$3,837,000
-31.1%
358,9040.0%1.16%
-28.2%
Q2 2021$5,570,000358,9041.61%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders